Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-17

Clinical Trial Update: Clinical Study of Cizutamig in Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of Cizutamig for systemic lupus erythematosus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cizutamig

Snippet

Sponsor: Candid Therapeutics | Conditions: Systemic Lupus Erythematosus (SLE) | Phase 1 | Status: RECRUITING